Immunity status against poliomyelitis in Germany: Determination of cut-off values in International Units
dc.contributor.author | Diedrich, Sabine | |
dc.contributor.author | Claus, Hermann | |
dc.contributor.author | Schreier, Eckart | |
dc.date.accessioned | 2018-05-07T14:45:41Z | |
dc.date.available | 2018-05-07T14:45:41Z | |
dc.date.created | 2011-09-01 | |
dc.date.issued | 2002-02-06 | none |
dc.identifier.other | http://edoc.rki.de/oa/articles/reOe5u4aTcig/PDF/28QMApmtDZNLw.pdf | |
dc.identifier.uri | http://edoc.rki.de/176904/925 | |
dc.description.abstract | Background: To prevent importations of wild polioviruses into a polio free region a high level of population immunity must be kept. Standard methodology for determination of polio antibodies is a feature aimed at obtaining consistent results. An International Standard Serum for polio antibodies exists, but no protective level in International Units is defined. Methods: A representative study was carried out in order to determine the serological status against poliomyelitis in Germany (n = 2564, age 18–79 years). Furthermore, sera from persons aged less than 18 years were included (n = 881). Microneutralization test has been used for determination of antibody levels. Results have been expressed in International Units. Results: The results of this study indicate that the cut-off level for polio antibodies is 0.075 IU/ml for Polio 1, 0.180 IU/ml for Polio 2 and 0.080 IU/ml for Polio 3. Neutralizing antibodies against poliovirus type 1, 2 and 3 were detected in 96.2%, 96.8% and 89.6% of samples, respectively. Conclusions: Overall, this seroprevalence indicates a very high level of immunity of the general population. It must be kept after the switch of immunization strategy from attenuated to inactivated vaccine in Germany. | eng |
dc.language.iso | eng | |
dc.publisher | Robert Koch-Institut, Infektionskrankheiten / Erreger | |
dc.subject | Adolescent | eng |
dc.subject | Humans | eng |
dc.subject | Female | eng |
dc.subject | Germany | eng |
dc.subject | Male | eng |
dc.subject | Middle Aged | eng |
dc.subject | Population Surveillance/methods | eng |
dc.subject | Adult | eng |
dc.subject | Aged | eng |
dc.subject | Age Factors | eng |
dc.subject | Sex Factors | eng |
dc.subject | Immunization Schedule | eng |
dc.subject | Antibodies Viral/blood | eng |
dc.subject | Disease Susceptibility/immunology | eng |
dc.subject | Immunity Innate | eng |
dc.subject | International System of Units/standards | eng |
dc.subject | Mathematical Computing | eng |
dc.subject | Neutralization Tests/standards | eng |
dc.subject | Poliomyelitis/epidemiology | eng |
dc.subject | Poliomyelitis/immunology | eng |
dc.subject | Poliomyelitis/prevention & control | eng |
dc.subject | Poliomyelitis/transmission | eng |
dc.subject | Poliovirus/immunology | eng |
dc.subject | Poliovirus Vaccines/therapeutic use | eng |
dc.subject | Reference Standards | eng |
dc.subject.ddc | 610 Medizin | |
dc.title | Immunity status against poliomyelitis in Germany: Determination of cut-off values in International Units | |
dc.type | periodicalPart | |
dc.identifier.urn | urn:nbn:de:0257-10015098 | |
dc.identifier.doi | 10.1186/1471-2334-2-2 | |
dc.identifier.doi | http://dx.doi.org/10.25646/850 | |
local.edoc.container-title | BMC Infectious Diseases | |
local.edoc.fp-subtype | Artikel | |
local.edoc.type-name | Zeitschriftenartikel | |
local.edoc.container-type | periodical | |
local.edoc.container-type-name | Zeitschrift | |
local.edoc.container-url | http://www.biomedcentral.com/1471-2334/2/2/abstract/ | |
local.edoc.container-publisher-name | BioMedCentral | |
local.edoc.container-volume | 2 | |
local.edoc.container-issue | 2 | |
local.edoc.container-year | 2002 |